Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
Carmen Mirabelli(University of Michigan), Jonathan Z. Sexton(University of Michigan)
Cited by 199
Related Papers
Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19
|bioRxiv (Cold Spring Harbor Laboratory)|2020|102
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
|Proceedings of the National Academy of Sciences|2023|8